Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

CpG ODN 1826 activates uveitogenic T-cells in mice

May 4, 2004

Promising topical ciclosporin prodrug against corneal graft rejection

May 3, 2004

PKC-412 improves retinal volume and visual acuity in DME patients

May 3, 2004

Vaccines suggested as an alternative for treating glaucoma

April 30, 2004

Adjunctive therapy with lerdelimumab after phacotrabeculectomy beneficial for IOP

April 30, 2004

Curcumin effective against human retinal endothelial cell proliferation

April 30, 2004

IND clearance for squalamine in neovascular diseases of the eye

April 26, 2004

Phase II trial of INS-37217 Ophthalmic for rhegmatogenous retinal detachment

April 26, 2004

Gatiflo eye drops receive Japanese approval

April 23, 2004

Alcon claims new 5-HT2 receptor agonists and their use as IOP lowering agents

April 20, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...